chr2-201272658-A-G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_001400671.1(CASP8):​c.-101A>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000309 in 1,614,154 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00032 ( 3 hom. )

Consequence

CASP8
NM_001400671.1 5_prime_UTR_premature_start_codon_gain

Scores

2
16

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:7

Conservation

PhyloP100: 0.108

Publications

9 publications found
Variant links:
Genes affected
CASP8 (HGNC:1509): (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008]
CASP8 Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome type 2B
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.04482758).
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.000322 (471/1461850) while in subpopulation MID AF = 0.0142 (82/5768). AF 95% confidence interval is 0.0117. There are 3 homozygotes in GnomAdExome4. There are 227 alleles in the male GnomAdExome4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001400671.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASP8
NM_001372051.1
MANE Select
c.432A>Gp.Ile144Met
missense
Exon 4 of 9NP_001358980.1Q14790-1
CASP8
NM_001400671.1
c.-101A>G
5_prime_UTR_premature_start_codon_gain
Exon 4 of 8NP_001387600.1
CASP8
NM_001400672.1
c.-101A>G
5_prime_UTR_premature_start_codon_gain
Exon 3 of 7NP_001387601.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASP8
ENST00000673742.1
MANE Select
c.432A>Gp.Ile144Met
missense
Exon 4 of 9ENSP00000501268.1Q14790-1
CASP8
ENST00000358485.8
TSL:1
c.609A>Gp.Ile203Met
missense
Exon 4 of 9ENSP00000351273.4Q14790-9
CASP8
ENST00000264275.9
TSL:1
c.528A>Gp.Ile176Met
missense
Exon 6 of 10ENSP00000264275.5Q14790-4

Frequencies

GnomAD3 genomes
AF:
0.000184
AC:
28
AN:
152186
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000274
AC:
69
AN:
251382
AF XY:
0.000250
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00179
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000378
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000322
AC:
471
AN:
1461850
Hom.:
3
Cov.:
33
AF XY:
0.000312
AC XY:
227
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.000119
AC:
4
AN:
33478
American (AMR)
AF:
0.0000894
AC:
4
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00130
AC:
34
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
0.0142
AC:
82
AN:
5768
European-Non Finnish (NFE)
AF:
0.000294
AC:
327
AN:
1111982
Other (OTH)
AF:
0.000248
AC:
15
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
26
52
79
105
131
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000184
AC:
28
AN:
152304
Hom.:
0
Cov.:
32
AF XY:
0.000175
AC XY:
13
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41570
American (AMR)
AF:
0.000196
AC:
3
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
68020
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000420
Hom.:
0
Bravo
AF:
0.000159
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000698
AC:
6
ExAC
AF:
0.000231
AC:
28
EpiCase
AF:
0.000273
EpiControl
AF:
0.000415

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
-
Autoimmune lymphoproliferative syndrome type 2B (3)
-
3
-
not provided (3)
-
1
-
CASP8-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
12
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.50
D
Eigen
Benign
-0.56
Eigen_PC
Benign
-0.64
FATHMM_MKL
Benign
0.39
N
LIST_S2
Benign
0.72
T
M_CAP
Benign
0.051
D
MetaRNN
Benign
0.045
T
MetaSVM
Benign
-0.56
T
MutationAssessor
Benign
1.8
L
PhyloP100
0.11
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-1.2
N
REVEL
Benign
0.14
Sift
Benign
0.17
T
Sift4G
Benign
0.15
T
Polyphen
0.0080
B
Vest4
0.18
MVP
0.90
MPC
0.37
ClinPred
0.012
T
GERP RS
-3.3
PromoterAI
0.0098
Neutral
Varity_R
0.16
gMVP
0.15
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149933993; hg19: chr2-202137381; API